Nice — I pulled together a compact, citation-backed market reference for the Insect Repellent Market with company references and the strategic bullets you asked for. I relied on recent industry reports and company filings; where companies don’t publicly break out a “repellent” line I note that and give the closest available value (company total revenue or reported business-unit facts). Citations follow each load-bearing claim.

Read complete report at: https://www.thebrainyinsights.com/report/insect-repellent-market-13178

Quick market snapshot

• Global market size (2024 / 2025 estimates): most analyst groups cluster around USD ~5.2–5.6 billion in 2024 (different vendors use slightly different scopes). Many forecasts show mid-single-digit to high-single-digit CAGR (~6–7% range) through the late-2020s.

• Larger scope / household insecticides overlap: some reports that include household insecticides (broader than personal repellents) give larger totals (mid- to high-USD billions). (Useful to pick the exact scope you want: personal repellents only vs household insecticides + repellents).

Reference list — major companies (with best-available values / notes)

1. Godrej Consumer Products (GCPL) — Brands: Goodknight, HIT (strong leadership in India and several emerging markets). Company FY23-24 consolidated revenue ~USD 1.7 billion (all segments); Godrej explicitly calls out household insecticides / Goodknight as a strategic, high-volume product in its FY24-25 reporting. Relevant product-market leadership and launches are documented in their reports.

2. S.C. Johnson & Son — Brands: OFF!, Raid (pest control/insecticide portfolio and new spatial/guardian-type repellent tech). SC Johnson is a large, private consumer group (company revenue ~$10–11B range reported by business media) and is widely listed as a top global player in repellents and household pest control.

3. Reckitt (RB) — Brands: Mortein (and other pest control brands via Essential Home / prior portfolio). Reckitt lists insect-control / home-care products among its global portfolios; Reckitt’s public filings show group net revenues (company-level) in its FY2024 reports. (RB also moved to divest / reorganize parts of its home/essential-home business in 2024–25).

4. Bayer — Brands / activities: Baygon and other pest-control brands in some markets (Bayer’s consumer / home products presence varies by geography). Bayer is a very large life-sciences group (group sales ~€46–47 billion in 2024), though insect-repellent product revenue is a small fraction of overall sales.

5. Spectrum Brands / Hot Shot / Other regional players — Spectrum and a range of regional players (Jyothi / Dabur in India historically, Tainwala chemicals, small local manufacturers) hold meaningful retail share in particular countries and channels (supermarkets, e-commerce). Industry reports list these firms among the top competitive set.

6. Other notable players / private label & regional champions: Jyothi Labs (Maxo in India), Dabur (Odomos & liquids), Bayer (where present), local formulators / ingredient suppliers, and many private-label manufacturers. Reports show that the market is a mix of global brands + strong national champions (especially in APAC and LATAM).

Recent developments

• Vector-borne disease outbreaks / travel alerts (2024–2025) (e.g., dengue, chikungunya events) have kept demand high for protective products and pushed governments/health agencies and consumers toward repellents and household insecticide solutions.

• Product/technology innovation — growth of spatial repellents, long-lasting passive devices (wearables, patches, Guardian-type hangable devices) and DEET-free / natural formulations. These innovations increase use-cases beyond traditional sprays/coils.

Drivers

• Rising incidence and geographic spread of mosquito-borne diseases (dengue, chikungunya, Zika, malaria) and heightened public-health awareness. 

• Urbanization, outdoor recreational lifestyles, and growth of travel/tourism increasing demand for personal repellents.

• Broader retail and e-commerce availability (subscriptions, DTC) that increase accessibility and repeat purchases.

Restraints

• Regulatory & safety scrutiny (claims, allowed active ingredients differ by country; consumer concern about DEET and other chemistries). 

• Raw material / active ingredient price & supply volatility for botanicals and specialty actives.

Regional segmentation (high-level)

• Asia-Pacific: largest regional share (APAC often cited as the dominant region — Grand View reports APAC ~41% revenue share in 2024) and fastest growth (high vector-borne disease burden + large population base).

• North America / Europe: mature markets, premium products, and regulatory rigor (consumers prefer clinically proven synthetics or regulated alternatives).

• Latin America / MEA: important growth pockets driven by mosquito seasonality and public health campaigns.

Emerging trends

• Movement to DEET-free / “natural” repellents (picaridin, IR3535, oil of lemon eucalyptus, botanical blends) as regulators and consumers seek safer options.

• Spatial and wearable repellents (longer duration, passive devices) gaining traction (SC Johnson Guardian and similar tech cited). 

• Channel shifts: e-commerce & subscription business models helping smaller brands scale quickly in select geographies.

Top use cases

1. Personal protection while travelling/outdoors (sprays, lotions, roll-ons)

2. Night-time household protection (vaporizers, coils, plug-ins)

3. Child & family everyday protection (safe topical formulations)

4. Institutional / humanitarian uses (spatial repellents, community interventions).

Major challenges

• Proving clinical efficacy (for premium pricing / claims). 

• Competing regulatory frameworks across markets (ingredient approvals, label claims).

• Price competition and heavy presence of low-cost local players in emerging markets.

Attractive opportunities

• Personalized / subscription DTC repellents (higher LTV, data for personalization).

• Ingredient innovation (microencapsulation for longer protection; new actives backed by trials).

• Public-private partnerships for community vector-control (combined with new spatial repellent tech).

Key factors of market expansion

1. Vector-borne disease incidence & public-health campaigns (drive urgency).

2. Product innovation (long-duration devices & safer actives).

3. Channel expansion (e-commerce + modern retail) + pricing segmentation (premium to mass).

4. Regulatory clarity or harmonization (would reduce time-to-market for cross-border launches).

Quick table (summary / at-a-glance)